Nations Financial Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,250
Closed -$538K 689
2024
Q4
$538K Sell
6,250
-10,988
-64% -$1.19M 0.04% 418
2024
Q3
$2.05M Sell
17,238
-3,255
-16% -$434K 0.15% 167
2024
Q2
$2.93M Buy
20,493
+5,261
+35% +$697K 0.24% 101
2024
Q1
$1.96M Sell
15,232
-12,732
-46% -$1.52M 0.16% 150
2023
Q4
$2.89M Sell
27,964
-839
-3% -$83K 0.27% 84
2023
Q3
$2.62M Buy
28,803
+1,389
+5% +$122K 0.26% 89
2023
Q2
$2.22M Buy
27,414
+206
+0.8% +$16.8K 0.22% 110
2023
Q1
$2.17M Buy
+27,208
New +$1.93M 0.23% 114
2022
Q3
Sell
-39,780
Closed -$2.22M 547
2022
Q2
$2.22M Buy
+39,780
New +$2.21M 0.3% 83
2022
Q1
Sell
-7,352
Closed -$412K 554
2021
Q4
$412K Sell
7,352
-198
-3% -$10.7K 0.05% 325
2021
Q3
$363K Buy
+7,550
New +$365K 0.06% 320

Other funds holding NVO

Nations Financial Group's NVO Position: Q1 2025 in Review

Nations Financial Group sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 6,250 shares — an estimated $538K sold.

Nations Financial Group first reported a position in NVO in Q3 2021 and held it in 11 quarters. The position peaked at $2.93M in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Nations Financial Group reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Nations Financial Group sold 6,250 Novo Nordisk shares in Q1 2025, an estimated $538K.
  • Nations Financial Group first reported a position in Novo Nordisk in Q3 2021 and held it in 11 quarters.
  • Nations Financial Group's Novo Nordisk position peaked at $2.93M in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Nations Financial Group's 13F filing for Q1 2025, filed 13 May 2025.